Adaptive Biotechnologies
ADPT
26.28
-0.62
-2.30%
Adaptive Biotechnologies
US · ADPT
#2184 by market cap
Listed 2019
26.28
-0.62
-2.30%
Live - 5344 symbols - heartbeat 69s ago
· 2026-10-08 09:10
Pre-market
26.16
-0.46%
After-hours
26.28
0.00%
Overnight
26.15
-0.49%
- Market cap
- 4.19B
- P/E (TTM)i
- -65.70
- P/Bi
- 29.36
- EPSi
- -0.39
- Div yieldi
- 0.00%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on ADPT?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
30.58 +16.4%
Price target rangecurrent 26.28
Low27.00
Avg30.58
High35.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | Guggenheim | -- | BUY | 32.00 |
| 2026-09-29 | Goldman Sachs | -- | BUY | 35.00 |
| 2026-09-22 | BTIG | -- | BUY | 34.00 |
| 2026-09-21 | BTIG | -- | BUY | 34.00 |
| 2026-09-17 | Craig-Hallum | -- | BUY | -- |
| 2026-08-24 | Piper Sandler | -- | BUY | 27.50 |
| 2026-08-04 | Piper Sandler | -- | BUY | 27.50 |
| 2026-07-30 | TD Cowen | -- | BUY | 28.00 |
| 2026-07-30 | William Blair | -- | BUY | -- |
| 2026-07-30 | BTIG | -- | BUY | 25.00 |
| 2026-07-30 | J.P. Morgan | -- | BUY | 27.00 |
| 2026-07-29 | TD Cowen | -- | BUY | 28.00 |
| 2026-07-29 | Guggenheim | -- | BUY | 25.00 |
| 2026-07-22 | BTIG | -- | BUY | 24.00 |
| 2026-07-15 | TD Cowen | -- | BUY | 25.00 |
| 2026-06-29 | Guggenheim | -- | BUY | 22.00 |
| 2026-05-12 | Piper Sandler | -- | BUY | 20.00 |
| 2026-05-12 | Morgan Stanley | -- | HOLD | 18.00 |
| 2026-05-06 | TD Cowen | -- | BUY | 21.00 |
| 2026-05-06 | Piper Sandler | -- | BUY | 20.00 |
| 2026-05-06 | BTIG | -- | BUY | 22.00 |
| 2026-05-06 | Guggenheim | -- | BUY | 21.00 |
| 2026-05-06 | J.P. Morgan | -- | BUY | 19.00 |
| 2026-05-05 | Craig-Hallum | -- | BUY | -- |
| 2026-05-05 | BTIG | -- | BUY | 22.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Buy
Analyst consensus
Buy
All 3 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-29 | After close | ±17.85% | +7.18% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±22.59% | +4.72% (in line) |
| 2025/Q4 | 2026-02-05 | After close | ±16.09% | -4.25% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±19.37% | -11.54% (in line) |
| 2025/Q2 | 2025-08-05 | After close | ±32.38% | +5.79% (in line) |
| 2025/Q1 | 2025-05-01 | After close | ±21.74% | +33.70% (beat) |
| 2024/Q4 | 2025-02-11 | After close | ±21.71% | -3.21% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±24.96% | +3.37% (in line) |
| 2024/Q2 | 2024-08-01 | After close | ±20.90% | -3.37% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±28.30% | +2.25% (in line) |
| 2023/Q4 | 2024-02-14 | After close | ±37.34% | +0.51% (in line) |
| 2023/Q3 | 2023-11-09 | After close | ±13.99% | -18.18% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 09:10:01 · For reference only, not investment advice and not tailored to your situation.